Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Pharming raises EUR 70M, ends royalty deal

Pharming (Euronext:PHARM) raised EUR 70 million ($99.2 million) through the sale of senior unsecured convertible bonds due 2012. The bonds

Read the full 206 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE